Aceto stocktwits
In connection with the acquisition of certain products and related assets from Citron Pharma, LLP and Lucid Pharma, LLP in December 2016, Aceto Corporation (the “Company”) and certain of its subsidiaries are contractually obligated to make a $50,000,000 deferred payment (the “Deferred Payment Amount”) to the sellers in that transaction OTC Markets | MDXG